227 related articles for article (PubMed ID: 10402474)
1. IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity.
Shiraha H; Glading A; Gupta K; Wells A
J Cell Biol; 1999 Jul; 146(1):243-54. PubMed ID: 10402474
[TBL] [Abstract][Full Text] [Related]
2. Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain.
Shiraha H; Glading A; Chou J; Jia Z; Wells A
Mol Cell Biol; 2002 Apr; 22(8):2716-27. PubMed ID: 11909964
[TBL] [Abstract][Full Text] [Related]
3. Glu-Leu-Arg-negative CXC chemokine interferon gamma inducible protein-9 as a mediator of epidermal-dermal communication during wound repair.
Satish L; Yager D; Wells A
J Invest Dermatol; 2003 Jun; 120(6):1110-7. PubMed ID: 12787142
[TBL] [Abstract][Full Text] [Related]
4. Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.
Satish L; Blair HC; Glading A; Wells A
Mol Cell Biol; 2005 Mar; 25(5):1922-41. PubMed ID: 15713646
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.
Chen P; Xie H; Sekar MC; Gupta K; Wells A
J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064
[TBL] [Abstract][Full Text] [Related]
6. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain.
Bodnar RJ; Yates CC; Wells A
Circ Res; 2006 Mar; 98(5):617-25. PubMed ID: 16484616
[TBL] [Abstract][Full Text] [Related]
7. m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate.
Leloup L; Shao H; Bae YH; Deasy B; Stolz D; Roy P; Wells A
J Biol Chem; 2010 Oct; 285(43):33549-33566. PubMed ID: 20729206
[TBL] [Abstract][Full Text] [Related]
8. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway.
Xie H; Pallero MA; Gupta K; Chang P; Ware MF; Witke W; Kwiatkowski DJ; Lauffenburger DA; Murphy-Ullrich JE; Wells A
J Cell Sci; 1998 Mar; 111 ( Pt 5)():615-24. PubMed ID: 9454735
[TBL] [Abstract][Full Text] [Related]
9. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of EGF-dependent mitogenesis by prostaglandin E2 in Syrian hamster embryo fibroblasts.
Hsi LC; Eling TE
Prostaglandins Leukot Essent Fatty Acids; 1998 Apr; 58(4):271-81. PubMed ID: 9654400
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway.
Glading A; Chang P; Lauffenburger DA; Wells A
J Biol Chem; 2000 Jan; 275(4):2390-8. PubMed ID: 10644690
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway.
Iwabu A; Smith K; Allen FD; Lauffenburger DA; Wells A
J Biol Chem; 2004 Apr; 279(15):14551-60. PubMed ID: 14747473
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cgamma and increase epithelial cell migration through indirect epidermal growth factor receptor activation.
Liu A; Garg P; Yang S; Gong P; Pallero MA; Annis DS; Liu Y; Passaniti A; Mann D; Mosher DF; Murphy-Ullrich JE; Goldblum SE
J Biol Chem; 2009 Mar; 284(10):6389-402. PubMed ID: 19129184
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin.
Shao H; Wu C; Wells A
J Biol Chem; 2010 Jan; 285(4):2591-600. PubMed ID: 19920151
[TBL] [Abstract][Full Text] [Related]
16. Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation.
Shao H; Chou J; Baty CJ; Burke NA; Watkins SC; Stolz DB; Wells A
Mol Cell Biol; 2006 Jul; 26(14):5481-96. PubMed ID: 16809781
[TBL] [Abstract][Full Text] [Related]
17. Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling.
Glading A; Uberall F; Keyse SM; Lauffenburger DA; Wells A
J Biol Chem; 2001 Jun; 276(26):23341-8. PubMed ID: 11319218
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
Hernández M; Barrero MJ; Crespo MS; Nieto ML
J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
[TBL] [Abstract][Full Text] [Related]
19. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors.
Shiraha H; Gupta K; Drabik K; Wells A
J Biol Chem; 2000 Jun; 275(25):19343-51. PubMed ID: 10764734
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
